FONAR PRESS RELEASE NEWS FONAR Corporation For Immediate Release The Inventor of MR Scanning Contact: Daniel Culver An ISO 9001 Company Director of Communications Melville, New York 11747 E-mail: investor@fonar.com Phone

Announces Fiscal 2017 2nd Quarter and Six Months Financial Results

22% Increase of 1st half, Fiscal 2017, Diluted Net Income per Common Share available to

Common Shareholders to $1.17, versus same six month period of prior year.

25% Increase of 1st half, Fiscal 2017, Net Income, to $9.4 million, versus same six month

period of prior year, including a $800,000 impact of deferred income tax benefits.

19% Increase of 1st half, Fiscal 2017, Income from Operations, to $9.4 million, versus same

six month period of prior year

3% Increase of 1st half, Fiscal 2017, Total Revenues - Net, to $37.1 million, versus

same six month period of prior year

February 9, 2017 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning ,

reported today its financial results for the 2nd Fiscal

Quarter of 2017 and the six month period ended December 31, 2016.

In 1980 FONAR birthed

the MRI industry with its installation of the first commercial whole-body MRI (Magnetic Resonance Imaging) scanner. Since then

the Company has manufactured and installed hundreds of MRIs the world over. While FONAR continues to manufacture and service its

products, the Company's primary source of income is derived from the management of 26 MRI centers though it subsidiary, Health

Management Company of America (HMCA). Twenty-five of the 26 centers feature the FONAR UPRIGHT Multi-Position MRI, aka

Stand-Up MRI, the only MRI scanner able to scan patients in normal full-weight-bearing positions.

extensive patent portfolio includes technology that enables Weight-Bearing MRI, allowing diagnosticians to view human anatomy in

its normal weight-bearing positions, including sitting, standing and bending. Certain anatomical regions are very sensitive to

body-position and gravity. For example, patients with lower back problems are often most uncomfortable when in a particular weight-bearing

position. If diagnosticians can evaluate the spine in those positions, they can minimize or completely avoid the risks of mischaracterizing

or underestimating the patients' problems. In light of the fact that most MRI exams are of the spine, this technology is

of great importance.

latest works-in-progress technology is aimed at visualizing and quantifying the flow of cerebrospinal fluid (CSF) throughout the

brain and vertebral column, which circulates at a rate of 32 quarts per day. The ability to image and quantify the dynamics of

this vital life-sustaining physiology of the body's neurologic system in all the normal positions of the body, particularly

in its upright flow against gravity, is made possible by FONAR technology.

CORPORATION AND SUBSIDIARIES

Operations, for the six month period ended December 31, 2016, increased 19% to $9.4 million as compared to $7.8 million for the

six month period ended December 31, 2015.

Operations, for the quarter ended December 31, 2016, increased 9% to $4.6 million as compared to $4.2 million for the quarter ended

for the six month period ended December 31, 2016, increased 25% to $9.4 million as compared to $7.6 million for the six month period

ended December 31, 2015.

for the quarter ended December 31, 2016, increased 20% to $4.9 million as compared to $4.1 million for the quarter ended December

- Net, for the six month period ended December 31, 2016, increased 3% to $37.1 million as compared to $36.0 million for the

six month period ended December 31, 2015.

- Net, for the quarters ended December 31, 2016 and 2015, was $18.4 million.

Available to Common Stockholders, for the six month period ended December 31, 2016, increased 23% to $7.3 million as compared to

$5.9 for the six month period ended December 31, 2015.

Available to Common Stockholders, for the quarter ended December 31, 2016, increased 22% to $4.0 million as compared to $3.3 million

for the quarter ended December 31, 2015.

Income per Common Share Available to Common Stockholders, for the six month period ended December 31, 2016, increased 22% to $1.17

per share as compared to $0.96 per share for the quarter ended December 31, 2015.

Income per Common Share Available to Common Stockholders, for the quarter ended December 31, 2016, increased 19% to $0.63 per share

as compared to $0.53 per share for the quarter ended December 31, 2015.

Income per Common Share Available to Common Stockholders, for the six month period ended December 31, 2016, increased 21% to $1.19

per share as compared to $0.98 per share for the quarter ended December 31, 2015.

Income per Common Share Available to Common Stockholders, for the quarter ended December 31, 2016, increased 19% to $0.64 per share

as compared to $0.54 per share for the quarter ended December 31, 2015.

at December 31, 2016, was $88.3 million, as compared to $84.9 million at June 30, 2016. Total Current Assets, at December 31, 2016,

was $48.4 million, as compared to $45.6 million at June 30, 2016.

at December 31, 2016, was $19.3 million, as compared to $24.1 million at June 30, 2016. Total Current Liabilities, at December

31, 2016, was $17.3 million, as compared to $20.6 million at June 30, 2016.

and Cash Equivalents, at December 31, 2016, was $7.7 million, as compared to $8.5 million at June 30, 2016.

FONAR CORPORATION AND SUBSIDIARIES

CEO Timothy R. Damadian said, "I am delighted to report that our bottom line EPS (Diluted Net Income Per Common Share Available

to Common Stockholders) has increased by 22% to $1.17 per share for the six months ended December 31, 2016, as compared to the

corresponding period one year earlier.

the uncertainties and challenges in today's healthcare arena, the HMCA management team is proud to have helped FONAR deliver

to its shareholders a steady annual growth rate of 6% over the past 6 years."

continued, "Our strategy of growing consistently while maintaining profitability is working nicely. We made key acquisitions

over the past several years, giving us the working capital and the cash flow needed for expansion. And, of course, we are always

looking for opportunities that will add to the success to our Company."

good news," said Raymond V. Damadian, M.D., Chairman of the Board of FONAR Corporation, "is that patients love our

UPRIGHT Multi-Position MRI scanner, which contributes to steady patient throughput! Patients who are claustrophobic

are very happy to be placed in the seated position and watch TV while they get their MRIs. For these patients, it can be a huge

relief. In addition, more and more physicians recognize the diagnostic value of scanning patients in fully weight-bearing positions,

particularly those patients getting MRIs of the spine.

growth and profitability has been positive and consistent in recent years and that's something to be proud of," continued

Dr. Damadian. "There were many years of struggle, but now FONAR has become a very successful Company. We owe our success

to the medical benefits of the FONAR UPRIGHT Multi-Position MRI, along with our management team's adherence to

a business plan designed to cope with a very uncertain and challenging healthcare environment. We have now achieved 27 consecutive

quarters (6 3/4 years) of profitability. And I am very grateful."

2017, Frost & Sullivan announced that Dr. Raymond Damadian, chairman of the Fonar Corporation, will receive special recognition

at the 22nd Annual Medical Technologies: A Frost & Sullivan Executive MindXchange, taking place March 19 to 21, 2017 at the

Loews Coronado Bay Resort in San Diego, Calif.

said: Dr. Damadian is the legendary inventor of the first MRI (Magnetic Resonance Imaging)

machine and the innovative mind responsible for saving thousands of lives. He will be presented with the Medtech Innovation Catalyst

Award, recognizing his contributions to medical device innovation. He is the recipient of numerous awards including the Lemelson-MIT

Lifetime Achievement Award, National Medal of Technology and has been inducted in the National Inventors Hall of Fame.

FONAR CORPORATION AND SUBSIDIARIES

of MR Scanning , is located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced

MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's

signature product is the FONAR UPRIGHT Multi-Position MRI (also known as the Stand-Up MRI), the only whole-body

MRI that performs Position Imaging (pMRI ) and scans patients in numerous weight-bearing positions, i.e. standing,

sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT

MRI often detects patient problems that other MRI scanners cannot because they are lie-down and "weightless"

only scanners. The patient-friendly UPRIGHT MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer

states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately

85% of patients are scanned sitting while watching TV.

works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central

nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the

rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body's

neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress

method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients

with whiplash or other neck injuries are among those who will benefit from this new understanding.

substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity

sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring